Ibrutinib plus rituximab versus ibrutinib monotherapy in patients with Waldenström macroglobulinemia: A pooled analysis

Alberto Guijosa, Andres Ramirez-Gamero, Shayna Sarosiek, Andrew Branagan, Gottfried von Keudell, Steven Treon, Jorge Castillo

Ibrutinib plus rituximab versus ibrutinib monotherapy in patients with Waldenström macroglobulinemia: A pooled analysis

American Society of Hematology Blood Advances Tracking no: ADV-2025-016536R1